METH use also lowers mRNA levels of HDAC3, HDAC8, and HDAC11, and reduces HDAC1 protein expression in the NAc, while increasing HDAC2 protein levels 3,80,103,104,105
GHK-Cu modulates the extracellular matrix, TB-500 the cytoskeleton and cell migration, and BPC-157 vascular and inflammation-related signaling pathways
There are no published clinical trial data evaluating this pairing, and it does not exist as a named investigational product or registered trial programme
To understand how oral BPC is absorbed, see our guide on the science behind oral BPC-157
Why Combination Treatments Matter Skin concerns rarely have a single cause